The Johns Hopkins Center for AIDS Research (JHU CFAR)
约翰霍普金斯大学艾滋病研究中心 (JHU CFAR)
基本信息
- 批准号:10268586
- 负责人:
- 金额:$ 125.36万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-09-23 至 2023-12-31
- 项目状态:已结题
- 来源:
- 关键词:AIDS/HIV problemAcquired Immunodeficiency SyndromeAddressAreaAwardBaltimoreBehavioralBiological AssayCitiesClinicalClinical ResearchCollaborationsCommunitiesContinuity of Patient CareDataDeveloping CountriesDevelopmentDiagnosisDisciplineEducation and OutreachEnvironmentEpidemicEpidemiologyEsapentExtramural ActivitiesFacultyFosteringFundingFutureGenerationsGoalsGrantHIVHealth OccupationsHeartIndividualInstitutionInterventionIntervention StudiesInvestmentsLaboratoriesLeadLeadershipMentorsMentorshipMinority GroupsMissionNCI Scholars ProgramParticipantPerformancePilot ProjectsPopulationProductivityPublic Health NursingReduce health disparitiesResearchResearch ActivityResearch DesignResearch MethodologyResearch PersonnelResearch SupportResearch TrainingResourcesSchoolsScienceServicesSocial JusticeSpecimenStudent recruitmentStudentsTimeTrainingUnderrepresented MinorityUnderrepresented PopulationsUnited States National Institutes of HealthUniversitiescareercollaboratorycombatcommunity based evaluationcommunity settingdesignexperiencegraduate studenthealth disparityinnovationinterdisciplinary collaborationmedical schoolsmedical specialtiesmemberminority investigatormultidisciplinarynext generationoutreachprogramsrecruitresearch studyresponsestudent participationsynergismundergraduate studentvirtualworking group
项目摘要
This is a competing renewal for the new Johns Hopkins University CFAR, initially funded in 2012. The new
CFAR had a complete change in leadership, a major reorganization, a number of new and highly innovative
approaches, and the enthusiastic and vigorous participation and support of the entire JHU HIV research
community and the institution's leaders, who have contributed $2.25 million of additional support to fund
additional developmental awards, student engagement, and outreach activities. For the past 4 years the
CFAR has reinvigorated the HIV community at JHU, built thriving platforms through which interdisciplinary
collaboration occurs, engaged new and junior investigators in cutting-edge research activities, provided vitally
needed developmental resources for conducting pilot studies that lead to extramural funding, and contributed
to the recruitment of new faculty, particularly 6 members of underrepresented minority groups. The CFAR has
served over 373 HIV investigators, >130 NIH grants, and provided mentoring and assistance to 212 early
stage investigators. Developmental Awards to early stage investigators or those new to HIV research have
resulted in $57 million in new extramural awards, and our Internal Scientific Reviews of NIH applications have
contributed to the funding of 14 new R01 or similar grants. The overall goal of this competing renewal
application is to continue and enhance the ability of the Johns Hopkins University CFAR to nurture and support
high-impact HIV research and researchers across a broad range of disciplines and specialties in the multiple
divisions of this major research university. Our specific aims are 1) to enhance the integration and productivity
of HIV/AIDS research by promoting inter-disciplinary innovation and collaboration; 2) to provide mentoring,
support, and pilot funding for the next generation of HIV/AIDS researchers, with a commitment to recruiting
researchers from underrepresented minority groups; 3) to support HIV/AIDS researchers with direct services to
assist with recruitment of clinical research participants, performance of laboratory assays, design and analysis
of research studies, and training in research methodologies; and 4) to mobilize and coordinate capacity from
across JHU to combat the HIV epidemic in Baltimore through engagement, training, outreach, and evaluation
of community-based intervention studies. The CFAR has 6 Cores and 3 Scientific Working Groups that provide
services and support innovation in high-priority HIV research. The Baltimore HIV Collaboratory, and its Plan
Baltimore 2020 project coordinate the JHU response to the local epidemic, orchestrating HIV research and
outreach activities, and expanding the pipeline of future HIV researchers through the Baltimore HIV Scholars
Program and Generation Tomorrow, initiatives aimed at students. The Provost and Deans of the 3 health
professions schools at JHU have committed institutional funds of $2.7 million to support pilot awards, student
recruitment, and Baltimore engagement. The CFAR will continue to have a galvanizing and transformative
impact on HIV/AIDS research at JHU and we are delighted to submit this renewal application.
这是对新的约翰·霍普金斯大学CFAR的竞争更新,最初是在2012年资助的。新的
CFAR发生了彻底的领导层更迭,进行了重大重组,有了一批新的和极具创新性的
方法,以及整个JHU艾滋病毒研究的热情和积极参与和支持
社区和该机构的领导人,他们捐赠了225万美元的额外支持,以资助
其他发展奖、学生参与和外展活动。在过去的4年里,
CFAR重振了JHU的艾滋病毒社区,建立了蓬勃发展的平台,通过这些平台
发生协作,让新的和初级的研究人员参与尖端研究活动,提供至关重要的
需要发展资源来开展试验性研究,从而获得外部资金,并为
关于招聘新教员,特别是6名代表不足的少数群体成员的问题。CFAR已经
为373名艾滋病毒研究人员提供服务,提供130笔NIH补助金,并在早期为212人提供指导和帮助
舞台调查员。向早期研究人员或艾滋病毒研究新手颁发的发展奖
产生了5700万美元的新的校外奖励,我们对NIH申请的内部科学审查
为14笔新的R01或类似赠款提供了资金。这一竞争性更新的总体目标是
申请是为了继续和提高约翰霍普金斯大学CFAR的培育和支持能力
在多个学科和专业中影响广泛的艾滋病毒研究和研究人员
这所主要研究型大学的分部。我们的具体目标是1)提高集成度和生产率
通过促进跨学科创新和合作,加强艾滋病毒/艾滋病研究;2)提供指导,
为下一代艾滋病毒/艾滋病研究人员提供支持和试点资金,并承诺招聘
来自代表性不足的少数群体的研究人员;3)为艾滋病毒/艾滋病研究人员提供直接服务,以
协助招募临床研究参与者、执行实验室分析、设计和分析
研究研究和研究方法培训;以及4)动员和协调来自
通过参与、培训、外展和评估,在整个JHU与巴尔的摩的艾滋病毒流行病作斗争
以社区为基础的干预研究。CFAR有6个核心和3个科学工作组,提供
在高优先级艾滋病毒研究方面提供服务和支持创新。巴尔的摩艾滋病毒合作实验室及其计划
巴尔的摩2020项目协调JHU对当地流行病的反应,协调艾滋病毒研究和
外展活动,并通过巴尔的摩艾滋病毒学者扩大未来艾滋病毒研究人员的渠道
计划和未来一代,以学生为目标的倡议。三大健康中心的教务长和院长
JHU职业学校承诺提供270万美元的机构资金来支持试点奖项,学生
招募,和巴尔的摩的参与。CFAR将继续具有激励性和变革性
对JHU艾滋病毒/艾滋病研究的影响,我们很高兴提交这份续签申请。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Richard E. Chaisson其他文献
Efficacy of Engineering Controls in Reducing Occupational Exposure to Aerosolized Pentamidine
- DOI:
10.1378/chest.102.6.1764 - 发表时间:
1992-12-01 - 期刊:
- 影响因子:
- 作者:
Melissa A. McDiarmid;John Schaefer;Cindy Lynn Richard;Richard E. Chaisson;Byron S. Tepper - 通讯作者:
Byron S. Tepper
The Impact of Prophylaxis on Outcome and Resource Utilization in <em>Pneumocystis carinii</em> Pneumonia
- DOI:
10.1378/chest.107.4.1018 - 发表时间:
1995-04-01 - 期刊:
- 影响因子:
- 作者:
Joel E. Gallant;Sharon M. McAvinue;Richard D. Moore;John G. Bartlett;David L. Stanton;Richard E. Chaisson - 通讯作者:
Richard E. Chaisson
Risk-stratified treatment for drug-susceptible pulmonary tuberculosis
药物敏感型肺结核的风险分层治疗
- DOI:
10.1038/s41467-024-53273-7 - 发表时间:
2024-10-30 - 期刊:
- 影响因子:15.700
- 作者:
Vincent K. Chang;Marjorie Z. Imperial;Patrick P. J. Phillips;Gustavo E. Velásquez;Payam Nahid;Andrew Vernon;Ekaterina V. Kurbatova;Susan Swindells;Richard E. Chaisson;Susan E. Dorman;John L. Johnson;Marc Weiner;Amina Jindani;Thomas Harrison;Erin E. Sizemore;William Whitworth;Wendy Carr;Kia E. Bryant;Deron Burton;Kelly E. Dooley;Melissa Engle;Pheona Nsubuga;Andreas H. Diacon;Nguyen Viet Nhung;Rodney Dawson;Radojka M. Savic - 通讯作者:
Radojka M. Savic
Tuberculosis Preventive Treatment in High TB-Burden Settings: A State-of-the-Art Review
- DOI:
10.1007/s40265-024-02131-3 - 发表时间:
2024-12-28 - 期刊:
- 影响因子:14.400
- 作者:
Violet Chihota;Makaita Gombe;Amita Gupta;Nicole Salazar-Austin;Tess Ryckman;Christopher J. Hoffmann;Sylvia LaCourse;Jyoti S. Mathad;Vidya Mave;Kelly E. Dooley;Richard E. Chaisson;Gavin Churchyard - 通讯作者:
Gavin Churchyard
Richard E. Chaisson的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Richard E. Chaisson', 18)}}的其他基金
JHU TRAC: Training and Supporting the Next Generation of TB Researchers
JHU TRAC:培训和支持下一代结核病研究人员
- 批准号:
10431020 - 财政年份:2022
- 资助金额:
$ 125.36万 - 项目类别:
JHU TRAC: Training and Supporting the Next Generation of TB Researchers
JHU TRAC:培训和支持下一代结核病研究人员
- 批准号:
10593142 - 财政年份:2022
- 资助金额:
$ 125.36万 - 项目类别:
Safety and Tolerability of Ultra-short Course Rifapentine and Isoniazid (1HP) for Prevention of Tuberculosis in HIV-Uninfected Individuals
超短疗程利福喷丁和异烟肼 (1HP) 用于预防未感染 HIV 个体结核病的安全性和耐受性
- 批准号:
10226377 - 财政年份:2020
- 资助金额:
$ 125.36万 - 项目类别:
Safety and Tolerability of Ultra-short Course Rifapentine and Isoniazid (1HP) for Prevention of Tuberculosis in HIV-Uninfected Individuals
超短疗程利福喷丁和异烟肼 (1HP) 用于预防未感染 HIV 个体结核病的安全性和耐受性
- 批准号:
10413161 - 财政年份:2020
- 资助金额:
$ 125.36万 - 项目类别:
Safety and Tolerability of Ultra-short Course Rifapentine and Isoniazid (1HP) for Prevention of Tuberculosis in HIV-Uninfected Individuals
超短疗程利福喷丁和异烟肼 (1HP) 用于预防 HIV 未感染者结核病的安全性和耐受性
- 批准号:
10631078 - 财政年份:2020
- 资助金额:
$ 125.36万 - 项目类别:
Safety and Tolerability of Ultra-short Course Rifapentine and Isoniazid (1HP) for Prevention of Tuberculosis in HIV-Uninfected Individuals
超短疗程利福喷丁和异烟肼 (1HP) 用于预防未感染 HIV 个体结核病的安全性和耐受性
- 批准号:
10018455 - 财政年份:2020
- 资助金额:
$ 125.36万 - 项目类别:
The Johns Hopkins Center for AIDS Research (JHU CFAR)
约翰霍普金斯大学艾滋病研究中心 (JHU CFAR)
- 批准号:
9322787 - 财政年份:2012
- 资助金额:
$ 125.36万 - 项目类别:
The Johns Hopkins Center for AIDS Research (JHU CFAR)
约翰霍普金斯大学艾滋病研究中心 (JHU CFAR)
- 批准号:
8843334 - 财政年份:2012
- 资助金额:
$ 125.36万 - 项目类别:
相似海外基金
RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
获得性免疫缺陷综合症分类的研究支持服务
- 批准号:
10219039 - 财政年份:2020
- 资助金额:
$ 125.36万 - 项目类别:
RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
获得性免疫缺陷综合症分类的研究支持服务
- 批准号:
9981476 - 财政年份:2019
- 资助金额:
$ 125.36万 - 项目类别:
IGF::OT::IGF RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
IGF::OT::IGF 针对获得性免疫缺陷综合症分类的研究支持服务
- 批准号:
9364184 - 财政年份:2016
- 资助金额:
$ 125.36万 - 项目类别:
Human Immunodeficiency Virus (HIV) and Acquired Immunodeficiency Syndrome (AIDS) in Saskatchewan- Where are we now and what does the future hold?
萨斯喀彻温省的人类免疫缺陷病毒(HIV)和获得性免疫缺陷综合症(艾滋病)——我们现在在哪里以及未来会怎样?
- 批准号:
236932 - 财政年份:2011
- 资助金额:
$ 125.36万 - 项目类别:
Miscellaneous Programs
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW COMMI
获得性免疫缺陷综合症研究审查委员会
- 批准号:
3554155 - 财政年份:1991
- 资助金额:
$ 125.36万 - 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW COMMI
获得性免疫缺陷综合症研究审查委员会
- 批准号:
3554156 - 财政年份:1991
- 资助金额:
$ 125.36万 - 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW
获得性免疫缺陷综合症研究综述
- 批准号:
2063342 - 财政年份:1991
- 资助金额:
$ 125.36万 - 项目类别: